Search PubMed⌕ Search

PubMed · 9183918

[Effect models and meta-analysis].

Abstract

The effect models are defined as the simple or complex relation that the risk in the treatment group follows when the risk in the control group varies. The standard statistical methods of meta-analysis are based on simple effect models. The use of these methods could induce inaccurate or erroneous results in more complex situations. In this case, it is necessary to adopt a more appropriate effect model, such as the linear effect model. The properties of this kind of model allow the possibility that a treatment can be beneficial and harmful at the same time, in function of the risk without treatment. From this observation, it is advisable to be careful with the use of simple effect models in meta-analysis which can submerge interesting information in the synthesis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Cucherat, J P Boissel. [Effect models and meta-analysis].. https://pubmed.ncbi.nlm.nih.gov/9183918/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Pharmacogenetics place in modern medical science and practice.

Pharmacogenetic evidence-based treatment strategies will have major implications for all aspects of the product pipeline, including drug discovery, high throughput target screening protocols, lead optimization, and drug formulation to produce series of medicines for a particular disease which will meet the efficacy needs of the majority of patients. The initial proof of principle experiments involves whole genome screening for DNA variants and determination of specific patterns of variants associated with adverse events of marketed products [SNP Print(sm)]. Pharmacogenetics has the potential of changing the pipeline model of drug discovery, clinical development, and mass customization marketing.

Drug Therapy↗

What patients want to know about their medications. Focus group study of patient and clinician perspectives.

OBJECTIVE: To describe what patients want to know about their medications and how they currently access information. To describe how physicians and pharmacists respond to patients' information needs. To use patients', physicians', and pharmacists' feedback to develop evidence-based treatment information sheets. DESIGN: Qualitative study using focus groups and a grounded-theory approach. SETTING: Three regions of Canada (British Columbia, Nova Scotia, and Ontario). PARTICIPANTS: Eighty-eight patients, 27 physicians, and 35 pharmacists each took part in one of 19 focus groups. METHOD: Purposeful and convenience sampling was used. A trained facilitator used a semistructured interview guide to conduct the focus groups. Analysis was completed by at least two research-team members. MAIN FINDINGS: Patients wanted both general and specific information when considering medication treatments. They wanted basic information about the medical condition being treated and specific information about side effects, duration of treatment, and range of available treatment options. Physicians and pharmacists questioned the amount of side-effect and safety information patients wanted and thought that too much information might deter patients from taking their medications. Patients, physicians, and pharmacists supported the use of evidence-based treatment information sheets. CONCLUSION: Patients and clinicians each appear to have a different understanding of what and how much information patients should receive about medications. Feedback from patients can be used to develop patient-oriented treatment information.

Drug Therapy↗